The Journal of Biomolecules, Pathogenesis and Therapeutics (JBPT) is committed to maintaining complete neutrality regarding jurisdictional, border, and geopolitical issues. We recognize that the global scientific community is highly diverse, and we actively foster an inclusive publishing environment that respects the scientific contributions and identities of all authors, editors, reviewers, and readers regardless of regional disputes.
All individuals involved in manuscript submissions are required to supply clear and verified data to preserve accurate scholarly attribution.
JBPT and its publisher, MSAR Institute, do not take an official stance, cross-validate boundaries, or pass judgment on territorial claims, sovereignty disputes, or the legal status of any country, region, or city referenced within affiliations or manuscript texts.
* Authors hold sole responsibility for ensuring geographic naming terminology is accurate and contextually appropriate. Handling editors retain final discretion to request text clarifications if geographic references are flagged as politically sensitive, ambiguous, or intentionally misleading.
Neither the JBPT Editorial Board nor the parent corporate body, Multidisciplinary Scholarly Advancement and Research MSAR Institute (SMC-Private) Limited, assumes any liability, legal accountability, or commercial responsibility for the empirical accuracy, methodological results, clinical efficacy, or drug safety profiles of any treatments, biomarkers, or data models published in the journal.
All scientific observations, biomedical claims, and medical interpretations rest entirely with the individual authors. Publication of content within JBPT does not constitute an endorsement, certificate of safety, or product validation by the publisher or affiliated health institutions.
